Peter Powchik

CIK 1377247 · SVP Clinical Development & Reg · last filed 2023-10-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.77M

Companies

2

Total Filings

30

Lifetime Open-Market Net

-$40.97M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Vaxxinity, Inc. (VAXX) Delisted Director 225,858 $0.11 $25.1K $0 4 2023-10-11
REGN SVP Clinical Development & Reg 27,388 $612.14 $16.77M -$40.97M 26 2016-12-19

Recent Filings · Page 3 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-08-02 REGN Exer (M) +14,990 $263.1K EDGAR
2012-07-27 REGN Mixed -$1.68M EDGAR
2012-02-23 REGN Mixed -$8.84M EDGAR
2011-12-20 REGN Grant (A) $0 EDGAR
2011-08-02 REGN Exer (M) +15,144 $236.9K EDGAR
2011-07-26 REGN Mixed -$1.00M EDGAR
2010-12-20 REGN Grant (A) $0 EDGAR
2009-12-22 REGN Grant (A) $0 EDGAR
2008-12-18 REGN Grant (A) $0 EDGAR
2007-12-19 REGN Grant (A) $0 EDGAR
Showing 2130 of 30
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.